logo
Select company
Select metric
$ 320KCurrent Debt
VS
Market
74
Sector
67
Industry
61
History
14
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information

Ticker

BBOT

Company Name

BRIDGEBIO ONCOLOGY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIDGEBIO ONCOLOGY THERAPEUTICS INC - Current Debt Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBOT - DebtC Historical data
DateCurrent Debt
6/30/2025$ 320K
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 70.09K
9/30/2023$ 43.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) DebtC stands at $ 43.4M.
  • Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average DebtC has been $ 5.47M.
  • The median DebtC for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was $ 0
  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest DebtC over the past 5 years at $ 43.4M.
  • The lowest DebtC recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe $ 0

Definition of Current Debt

[Balance Sheet] The current (short-term) portion of [Debt] includes the formal borrowings that are due within a year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]

BBOT - Current Debt, Last 5 years

$ 0

Minimum

Mar 31, 2024

$ 43.4M

Maximum

Sep 30, 2023

$ 5.47M

Average

$ 0

Median

DebtC Benchmark Analysis

The chart above depicts the distribution of DebtC for companies in the Total Stock Market. The average DebtC of the companies is $ 5.45M with a standard deviation of $ 8.14M.
The following table provides additional summary stats:
DebtC in the Market:
filtered constituents2.58K
min$ 0
max$ 35.16M
average$ 5.45M
median$ 1.25M
std$ 8.14M